This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Exploring the potential of Roche's trontinemab and Elecsys® pTau181 plasma test in revolutionizing Alzheimer’s diagnosis and treatment

Ticker(s): RHHBY

Who's the expert?

Institution: First Choice Neurology

  • Former Assistant Professor of Neurology at the University of Miami School of Medicine
  • Board Certified by the American Board of Psychiatry and Neurology.  
  • Practices general adult and adolescent neurology with special interest in electromyography (EMG), neuromuscular and spinal disorders, migraine, vertigo, and Dementia
  • Has participated in many scientific research studies including diabetic neuropathy and Alzheimer’s disease.

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.